A detailed history of Townsquare Capital LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Townsquare Capital LLC holds 11,018 shares of ADPT stock, worth $51,564. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,018
Holding current value
$51,564
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.37 - $5.12 $37,130 - $56,412
11,018 New
11,018 $56,000
Q3 2023

Nov 15, 2023

SELL
$5.07 - $8.44 $654 - $1,088
-129 Reduced 1.07%
11,949 $65,000
Q2 2023

Nov 13, 2023

SELL
$6.19 - $8.78 $210 - $298
-34 Reduced 0.28%
12,078 $81,000
Q1 2023

May 11, 2023

BUY
$7.8 - $10.11 $11,590 - $15,023
1,486 Added 13.98%
12,112 $106,000
Q4 2022

Feb 13, 2023

BUY
$6.26 - $9.34 $66,518 - $99,246
10,626 New
10,626 $81,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $669M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Townsquare Capital LLC Portfolio

Follow Townsquare Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Townsquare Capital LLC with notifications on news.